Learn more about our product portfolios:
Our broad portfolio is the foundation from which we make healthy possible. In the US, our generics portfolio of more than 250 medicines provides patients with more affordable access to quality medicines. Our growing Specialty Pharma business delivers products that meet important medical needs in central nervous system disorders, endocrinology and other therapeutic categories. We are also excited about our work to bring patients more affordable biologic therapy options through our Biosciences business, which today includes a broad portfolio of institutional injectables as well as Amneal’s growing biosimilars portfolio. And we’re working to expand our generics business across select international markets.